Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Amodiaquine and SP in Cameroon
NCT00146718Phase 3Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Aug 2003
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of amodiaquine and sulfadoxine + pyrimethamine in Plasmodium falciparum malaria (3 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoint: Adequate Clinical and Parasitological Response at Day 28. Started Aug 2003; status: completed.
02
Drugs
amodiaquinesulfadoxine + pyrimethamine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT00146718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00146718.